Plus   Neg

Oxford Instruments 5-month Cumulative Revenue Down 2%

Oxford Instruments plc.(OXIG.L) said that the coronavirus has continued to have an impact on trading in the first five months of the year, with cumulative revenue down 2% against last year.

Revenue has been supported by a strong uplift in shipments of compound semiconductor process solutions and installations of cryogenic and magnet systems. It has partially offset lower revenue to academic markets for our scientific cameras, microscopy products and electron analysers, due to continued covid-19 disruption.

The company said it has seen modest order growth over the first five months of trading and a good improvement in the order book.

The company said it will release its results for the half year ended 30 September 2020 on 10 November 2020.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Telecom giant AT&T, Inc. reported Thursday a 24 percent decline in profit for the third quarter, primarily hurt by lower revenues across all its operating segments amid the impact from COVID-19 pandemic. Adjusted earnings for the quarter met analysts' expectations, while quarterly revenues topped their estimates. A Brazilian volunteer, who participated in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University, has died, Brazilian health authority Anvisa said. Oxford university reportedly confirmed the plan to continue the trial after careful assessment that there have been no concerns about safety of the clinical trial. NASA's Osiris-Rex robotic spacecraft briefly touched down on near-Earth asteroid Bennu's surface on Tuesday to collect rock and dust samples that will be brought back to Earth in 2023. Bennu is currently more than 200 million miles, or 321 million kilometres, from Earth. Osiris-Rex launched from Cape Canaveral Air Force Station in Florida in September 2016.
Follow RTT